Realta Life Sciences, Inc.
Clinical trials sponsored by Realta Life Sciences, Inc., explained in plain language.
-
New hope for transplant patients: experimental drug targets deadly immune complication
Disease control Recruiting nowThis study tests an experimental drug called RLS-0071 in 66 hospitalized patients who have a serious complication after a stem cell transplant called graft-versus-host disease (GVHD) that hasn't improved with steroids. The goal is to find the best dose and see if the drug is safe…
Phase: PHASE2 • Sponsor: ReAlta Life Sciences, Inc. • Aim: Disease control
Last updated May 26, 2026 03:43 UTC
-
New drug could save newborn brains after oxygen loss
Disease control Recruiting nowThis study tests a new medicine called RLS-0071 in 70 newborns who have moderate to severe brain injury from lack of oxygen at birth (HIE). All babies will receive standard cooling therapy, and some will also get the study drug or a placebo. The goal is to see if the drug is safe…
Phase: PHASE2 • Sponsor: ReAlta Life Sciences, Inc. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC